Metagenomi Therapeutics【MGX】銘柄情報

Metagenomi Therapeutics Inc (MGX) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

1.25

( 5.04% )

買値

1.19

売値

1.30

出来高

208,654

1.21 日の範囲 1.305

1.13 52 週間の範囲 3.89

時価総額

47.059M

前日終値

1.19

始値

1.21

時刻

1.25

最終取引時間

財務取引量

US$ 259,636

VWAP

1.2443

平均取引量 (3 か月)

US$ 176,639

発行済株式数

37,646,858

配当利回り

PER

-0.52

1 株当たり利益 (EPS)

-2.3

歳入

22.33M

純利益

-85.89M

Metagenomi Therapeutics, Inc. an in vivo genome editing company, develops curative genetic medicines in the United States. The company’s lead development program, MGX-001, is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophil... Metagenomi Therapeutics, Inc. an in vivo genome editing company, develops curative genetic medicines in the United States. The company’s lead development program, MGX-001, is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia. It has a collaboration agreement with Ionis Pharmaceuticals, Inc. for apolipoprotein C-III for the treatment of hyper triglyceridemia, transthyretin (TTR) for transthyretin amyloidosis, angiotensinogen (AGT) for refractory hypertension, and other programs. The company was formerly known as Metagenomi, Inc. and changed its name to Metagenomi Therapeutics, Inc. in January 2026. Metagenomi Therapeutics, Inc. was incorporated in 2016 and is headquartered in Emeryville, California. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

metagenomi.co

本社

Emeryville, United States

設立

2026

Metagenomi Therapeutics Inc is listed in the Healthcare sector of the ナスダック市場 with ticker MGX. The last closing price for Metagenomi Therapeutics was US$1.19. Over the last year, Metagenomi Therapeutics shares have traded in a share price range of US$ 1.13 to US$ 3.89.

Metagenomi Therapeutics currently has 37,646,858 shares in issue. The market capitalisation of Metagenomi Therapeutics is US$47.06 million. Metagenomi Therapeutics has a price to earnings ratio (PE ratio) of -0.52.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.06	5.04201680672	1.19	1.29	1.16	83131	1.20268255	CS
4	-0.14	-10.071942446	1.39	1.3999	1.13	144200	1.24541388	CS
12	-0.08	-6.01503759398	1.33	1.55	1.13	166179	1.35132783	CS
26	-0.48	-27.7456647399	1.73	1.86	1.13	218849	1.49029198	CS
52	-0.31	-19.8717948718	1.56	3.89	1.13	416585	2.07719367	CS
156	-9	-87.8048780488	10.25	12.74	1.13	534865	3.07935336	CS
260	-9	-87.8048780488	10.25	12.74	1.13	534865	3.07935336	CS